Thailand to sell generic Viagra drug: officials
September 26, 2012 in Medications
Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.
The Thai diamond-shaped little blue pill, which resembles the original produced by US pharmaceutical giant Pfizer, is called "Sidegra" and will be available on prescription across the country on October 1.
Priced at 25 baht (80 US cents) per pill, Thailand's Food and Drug Administration (FDA) said it will be ten times cheaper than full-price Viagra.
"This measure will solve widespread production of fake drugs by increasing accessibility to the legal version," FDA secretary general Pipat Yingseree said in a statement.
The release said Pfizer had since looked to discount its pills by 30 percent to "cooperate with the government on curbing fake drugs".
"Pfizer is selling at a discount to be able to compete with our Sidegra," said an official at the state-run Government Pharmaceutical Organisation, which is producing the drug.
No one from Pfizer's offices in Thailand was available for comment.
An FDA official said the US company's patent to produce the anti-impotence drug had expired in Thailand.
Fake sex drugs are openly on sale on street stalls targeting tourists around the red light districts of the Thai capital.
In a raid on a Bangkok warehouse in July, Thai police seized several hundred thousand purported sex enhancement and aphrodisiac pills and a large haul of sex toys, worth an estimated $3.2 million.
(c) 2012 AFP
-
S. Korea to approve Viagra generics
Mar 14, 2012 |
not rated yet |
0
-
Internet led to global 'explosion' of fake drugs
Jun 14, 2012 |
not rated yet |
0
-
US approves India's Ranbaxy to make generic Lipitor
Dec 01, 2011 |
not rated yet |
0
-
Slovenia to launch generic version of Viagra
Jul 31, 2009 |
not rated yet |
0
-
China arrests nearly 2,000 in fake drug crackdown
Aug 06, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
3 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Analgesics prescribed more heavily to women than to men, study finds
Regardless of pain, social class or age, a woman is more likely to be prescribed pain-relieving drugs. A study published in Gaceta Sanitaria (Spanish health scientific journal) affirms that this phenomenon is inf ...
Medications
1 hour ago |
not rated yet |
0
Breakup of physician, drug company relationship could improve health care, cut cost
A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, ...
Medications
22 hours ago |
5 / 5 (1) |
0
FDA has safety concerns on Merck insomnia drug
Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.
Medications
23 hours ago |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Medications
May 20, 2013 |
5 / 5 (1) |
0
Acne pill benefits outweigh blood clot risk: EU agency
Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.
Medications
May 17, 2013 |
not rated yet |
0
Exercise levels may predict hospitalizations in COPD population
Clinical measurement of physical activity appears to be an independent predictor of whether or not patients with chronic obstructive pulmonary disease (COPD) will end up being hospitalized, according to a new study conducted ...
Delayed transfer to the ICU increases risk of death in hospital patients
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
Racial disparities in the surgical management of non-small cell lung cancer
The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.
Study shows where scene context happens in our brain
In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...
Monoclonal antibody appears effective and safe in asthma Phase IIa trial
A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.
New rice contamination reported in China
Authorities are investigating rice mills in southern China following tests that found almost half of the staple grain in one of the country's largest cities was contaminated with a toxic metal.